Selected research
Industry Research
Estradiol Patches Industry Research Report 2026
Market perspective
The global Estradiol Patches market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Estradiol Patches is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Estradiol Patches is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Estradiol Patches is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Estradiol Patches include Amneal Pharmaceuticals, Hisamitsu, Mylan, Noven, Theramex, AbbVie, Bayer, Novartis and Yatai Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Estradiol Patches market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Estradiol Patches Market by Company
Amneal Pharmaceuticals
Hisamitsu
Mylan
Noven
Theramex
AbbVie
Bayer
Novartis
Yatai Pharma
Estradiol Patches Segment by Type
Estradiol-only Patches
Combination Patches (Estradiol + Progestin)
Estradiol Patches Segment by Application
Post-Hysterectomy Therapy
Hormone Replacement Therapy (HRT) in Transgender Women
Menopause-Related Symptoms
Hypoestrogenism
Others
Estradiol Patches Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Estradiol Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Estradiol Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Estradiol Patches.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Estradiol Patches manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Estradiol Patches by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Estradiol Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Estradiol-only Patches
- Combination Patches (Estradiol + Progestin)
Applications
- Post-Hysterectomy Therapy
- Hormone Replacement Therapy (HRT) in Transgender Women
- Menopause-Related Symptoms
- Hypoestrogenism
- Others
Companies covered
- Amneal Pharmaceuticals
- Hisamitsu
- Mylan
- Noven
- Theramex
- AbbVie
- Bayer
- Novartis
- Yatai Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Estradiol Patches Market Size (2021-2032)
- 2.2.2 Global Estradiol Patches Sales (2021-2032)
- 2.2.3 Global Estradiol Patches Market Average Price (2021-2032)
- 2.3 Estradiol Patches by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Estradiol-only Patches
- 2.3.3 Combination Patches (Estradiol + Progestin)
- 2.4 Estradiol Patches by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Post-Hysterectomy Therapy
- 2.4.3 Hormone Replacement Therapy (HRT) in Transgender Women
- 2.4.4 Menopause-Related Symptoms
- 2.4.5 Hypoestrogenism
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Estradiol Patches Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Estradiol Patches Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Estradiol Patches Revenue of Manufacturers (2021-2026)
- 3.4 Global Estradiol Patches Average Price by Manufacturers (2021-2026)
- 3.5 Global Estradiol Patches Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Estradiol Patches, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Estradiol Patches, Product Type & Application
- 3.8 Global Manufacturers of Estradiol Patches, Established Date
- 3.9 Global Estradiol Patches Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Amneal Pharmaceuticals
- 4.1.1 Amneal Pharmaceuticals Company Information
- 4.1.2 Amneal Pharmaceuticals Business Overview
- 4.1.3 Amneal Pharmaceuticals Estradiol Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Amneal Pharmaceuticals Estradiol Patches Product Portfolio
- 4.1.5 Amneal Pharmaceuticals Recent Developments
- 4.2 Hisamitsu
- 4.2.1 Hisamitsu Company Information
- 4.2.2 Hisamitsu Business Overview
- 4.2.3 Hisamitsu Estradiol Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Hisamitsu Estradiol Patches Product Portfolio
- 4.2.5 Hisamitsu Recent Developments
- 4.3 Mylan
- 4.3.1 Mylan Company Information
- 4.3.2 Mylan Business Overview
- 4.3.3 Mylan Estradiol Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mylan Estradiol Patches Product Portfolio
- 4.3.5 Mylan Recent Developments
- 4.4 Noven
- 4.4.1 Noven Company Information
- 4.4.2 Noven Business Overview
- 4.4.3 Noven Estradiol Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Noven Estradiol Patches Product Portfolio
- 4.4.5 Noven Recent Developments
- 4.5 Theramex
- 4.5.1 Theramex Company Information
- 4.5.2 Theramex Business Overview
- 4.5.3 Theramex Estradiol Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Theramex Estradiol Patches Product Portfolio
- 4.5.5 Theramex Recent Developments
- 4.6 AbbVie
- 4.6.1 AbbVie Company Information
- 4.6.2 AbbVie Business Overview
- 4.6.3 AbbVie Estradiol Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 AbbVie Estradiol Patches Product Portfolio
- 4.6.5 AbbVie Recent Developments
- 4.7 Bayer
- 4.7.1 Bayer Company Information
- 4.7.2 Bayer Business Overview
- 4.7.3 Bayer Estradiol Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bayer Estradiol Patches Product Portfolio
- 4.7.5 Bayer Recent Developments
- 4.8 Novartis
- 4.8.1 Novartis Company Information
- 4.8.2 Novartis Business Overview
- 4.8.3 Novartis Estradiol Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Novartis Estradiol Patches Product Portfolio
- 4.8.5 Novartis Recent Developments
- 4.9 Yatai Pharma
- 4.9.1 Yatai Pharma Company Information
- 4.9.2 Yatai Pharma Business Overview
- 4.9.3 Yatai Pharma Estradiol Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Yatai Pharma Estradiol Patches Product Portfolio
- 4.9.5 Yatai Pharma Recent Developments
5 Global Estradiol Patches Market Scenario by Region
- 5.1 Global Estradiol Patches Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Estradiol Patches Sales by Region: 2021-2032
- 5.2.1 Global Estradiol Patches Sales by Region: 2021-2026
- 5.2.2 Global Estradiol Patches Sales by Region: 2027-2032
- 5.3 Global Estradiol Patches Revenue by Region: 2021-2032
- 5.3.1 Global Estradiol Patches Revenue by Region: 2021-2026
- 5.3.2 Global Estradiol Patches Revenue by Region: 2027-2032
- 5.4 North America Estradiol Patches Market Facts & Figures by Country
- 5.4.1 North America Estradiol Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Estradiol Patches Sales by Country (2021-2032)
- 5.4.3 North America Estradiol Patches Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Estradiol Patches Market Facts & Figures by Country
- 5.5.1 Europe Estradiol Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Estradiol Patches Sales by Country (2021-2032)
- 5.5.3 Europe Estradiol Patches Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Estradiol Patches Market Facts & Figures by Country
- 5.6.1 Asia Pacific Estradiol Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Estradiol Patches Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Estradiol Patches Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Estradiol Patches Market Facts & Figures by Country
- 5.7.1 South America Estradiol Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Estradiol Patches Sales by Country (2021-2032)
- 5.7.3 South America Estradiol Patches Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Estradiol Patches Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Estradiol Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Estradiol Patches Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Estradiol Patches Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Estradiol Patches Sales by Type (2021-2032)
- 6.1.1 Global Estradiol Patches Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Estradiol Patches Sales Market Share by Type (2021-2032)
- 6.2 Global Estradiol Patches Revenue by Type (2021-2032)
- 6.2.1 Global Estradiol Patches Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Estradiol Patches Revenue Market Share by Type (2021-2032)
- 6.3 Global Estradiol Patches Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Estradiol Patches Sales by Application (2021-2032)
- 7.1.1 Global Estradiol Patches Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Estradiol Patches Sales Market Share by Application (2021-2032)
- 7.2 Global Estradiol Patches Revenue by Application (2021-2032)
- 7.2.1 Global Estradiol Patches Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Estradiol Patches Revenue Market Share by Application (2021-2032)
- 7.3 Global Estradiol Patches Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Estradiol Patches Value Chain Analysis
- 8.1.1 Estradiol Patches Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Estradiol Patches Production Mode & Process
- 8.2 Estradiol Patches Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Estradiol Patches Distributors
- 8.2.3 Estradiol Patches Customers
9 Global Estradiol Patches Analyzing Market Dynamics
- 9.1 Estradiol Patches Industry Trends
- 9.2 Estradiol Patches Industry Drivers
- 9.3 Estradiol Patches Industry Opportunities and Challenges
- 9.4 Estradiol Patches Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst